ABL2 and MAP3K10

  • Number of citations of the paper that reports this interaction (PMID 20936779)
  • 48
  • Data Source:
  • BioGRID (two hybrid)

ABL2

MAP3K10

Gene Name ABL proto-oncogene 2, non-receptor tyrosine kinase mitogen-activated protein kinase kinase kinase 10
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 25 interactors: ABL1 BCR C15orf48 CAT CRK DOK1 EGFR EPHB2 ERBB2 ERBB3 ERBB4 FBXO38 GPX1 GRB2 HCK MAP3K10 NEDD4 NEDD4L OIP5 PSMA7 RIN1 SIVA1 SORBS2 TPD52L1 TRIP10 30 interactors: ABL2 CDC42 CEACAM1 CLTC CNKSR1 COPS2 DLG4 DNM1 DNM1L GARS HGS HTT KIAA1804 KIF17 KIF3A KIF3B KIFAP3 MAP2K4 MAPK1 MAPK14 MAPK8IP1 MAPK8IP2 MAPK9 NEUROD1 PHB RAC1 RACGAP1 SH3RF1 TUBB YWHAE
Entrez ID 27 4294
HPRD ID 01259 02533
Ensembl ID ENSG00000143322 ENSG00000130758
Uniprot IDs P42684 Q02779
PDB IDs 2ECD 2KK1 2XYN 3GVU 3HMI 3ULR 4EIH 2RF0
Enriched GO Terms of Interacting Partners?
Tagcloud ?
abl1  adding  amenable  charities  crizotinib  crlf2  csf1r  dasatinib  epor  etv6  flt3  funded  fusions  il7r  lebanese  lymphoblastic  ntrk3  pdgfrb  ph  philadelphia  ptk2b  rearrangements  responsiveness  ruxolitinib  sh2b3  syrian  tslp  tyk2  undefined 
artp  calculating  chief  convergence  dusp2  hrgg  il2ra  il6  il8ra  il8rb  infgr1  irf2  merits  mmp1  nfkb1a  nos2a  partp  pik3ca  polygenic  pttrnd  raf1  rectal  runx3  sepx1  smad3  soc  strongest  truncation  tyk2 
Tagcloud (Difference) ?
abl1  adding  amenable  charities  crizotinib  crlf2  csf1r  dasatinib  epor  etv6  flt3  funded  fusions  il7r  lebanese  lymphoblastic  ntrk3  pdgfrb  ph  philadelphia  ptk2b  rearrangements  responsiveness  ruxolitinib  sh2b3  syrian  tslp  undefined 
artp  calculating  chief  convergence  dusp2  hrgg  il2ra  il6  il8ra  il8rb  infgr1  irf2  merits  mmp1  nfkb1a  nos2a  partp  pik3ca  polygenic  pttrnd  raf1  rectal  runx3  sepx1  smad3  soc  strongest  truncation 
Tagcloud (Intersection) ?
tyk2